The change of neutrophils/lymphocytes ratio in migraine attacks: A case-controlled study

Annals of Medicine and Surgery

Volumn 10, Issue , 2016, Pages 52-56

  Karabulut, Keziban Ucar ^a   Egercioglu, Tomris Ugur ^a   Uyar, Mehmet ^b   Ucar, Yildiz ^c  

^a BASKENT UNIVERSITY   (Turkey)

^b NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^c Diclekent   (Turkey)

Author keywords

Headaches; Inflammation; Migraine; Neutrophil lymphocyte ratio

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

EID: 84982893572     PISSN: 20490801     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amsu.2016.07.023     Document Type: Article

References (30)

1. [1] Ang, Seng Hock, Chan, Yee Cheun, Mahadevan, Malcolm, Emergency department headache admissions in an acute care hospital: why do they occur and what can we do about it?. Ann. Acad. Med. Singap. 38 (2009), 1007–1010.
2. [2] Headache Classification Commitee of the International Headache Society 2003, The international classification of headache disorders. Cephalalgia, 24(1), 2004.
3. [3] Henry, G.L., Headache. Rosen, P., Barkin, M.R., (eds.) Emergency Medicine Consepts and Clinical Practice, fourth ed., 1998, Mosby-Year Book, St.Louis, 2119–2131.
4. [4] D'Amico, D., Usai, S., Grazzi, L., et al. Disability and migraine: MDAS. J. Headache Pain 2 (2001), 25–27.
5. [5] Headache. Rosen, P., Barkin, R.M., Hayden, S.R., Schaider, J., (eds.) Wolfe R.the 5 Minutes Emergency Medicine Consult, 1999, Lippincott Williams & Wilkins, Philedelphia, 476–477.
6. [6] Bussone, G., Grazzi, L., Usai, S., et al. Disability in migraine patients Italian experience. J. Headache Pain 2 (2001), 29–31.
7. [7] Welch, K.M.A., Nagesh, V., Aurora, S.K., Gelman, N., Periaqueductal gray matter dysfunction in migraine. Cause or burden of illness?. Headache 41 (2001), 629–637.
8. [8] Vanmolkot, F.H., de Hoon, J.H., Increased C-reactive protein in young adult patients with migraine. Cephalalgia 27 (2007), 843–846.
9. [9] Zahorec, R., Ratio of neutrophil to lymphocyte counts—Rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl. Lek. Listy 102 (2001), 5–14.
10. [10] Gomez, D., Farid, S., Malik, H.Z., Young, A.L., Lodge, J.P., Prasad, K.R., Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J. Surg. 32:8 (2008), 1757–1762.
11. [11] Azab, B., Bhatt, V.R., Phookan, J., Murukutla, S., Kohn, N., Widmann, W.D., Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann. Surg. Oncol. 19:1 (2012), 217–224.
12. [12] Celentano, D.P., Stewart, W.F., Linet, M.S., The relationship of headache symptoms with severety and duration of attacks. J. Clin. Epidemiol. 43 (1990), 983–999.
13. [13] Özge, A., Buğdaycı, R., Şaşmaz, T., Kaleağası, H., Kurt, Ö., Karakelle, A., Tezcan, H., Siva, A., The Sensitivity and specificity of the case definition criteria in diagnosis of headache. Cephalgia 22 (2002), 791–798.
14. [14] Hayran, O., Zarifoglu, M., Siva, A., Başağrısı epidemiyolojisi. Erdine, S., (eds.) Ağrı, 2000, 181–183.
15. [15] Zeller, J.A., Lindner, V., Frahm, K., Baron, R., Deuschl, G., Platelet activation and platelet-leucocyte interaction in patients with migraine. Subtype differences and influence of triptans. Cephalalgia 25 (2005), 536–541.
16. [16] Varol, Sefer, Akıl, Esref, Ugur, Mehmet, et al. Investigation of mean platelet volume and platelet count in the blood of patients with migraine. Turk. J. Neurol., 19, 2013, 3, 10.4274/Tnd.88156.
17. [17] Admont, A.H., Borch-Iohnsen, B., Hagen, K., Stovner, L.J., Asberg, A., Zwart, J.-A., Headache prevalence related to haemoglobin and ferritin. Cephalalgia 24 (2004), 758–762.
18. [18] Vanmolkot, F.H., de Hoon, J.H., Increased C-reactive protein in young adult patients with migraine. Cephalalgia 27 (2007), 843–846.
19. [19] Gudmundsson, L.S., Aspelund, T., Scher, A.I., et al. C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study. Cephalalgia 29:12 (2009 Dec), 1301–1310.
20. [20] Welch KMWelch, K.M., Stroke and migraine the spectrum of cause and effect. Funct. Neurol. 18 (2003), 121–126.
21. [21] da Costa, S.C., Passos, I.C., Réus, G.Z., Carvalho, A.F., Soares, J.C., Quevedo, J., The Comorbidity of bipolar disorder and migraine: the role of inflammation and oxidative and nitrosative stress. Curr. Mol. Med. 16:2 (2016), 179–186.
22. [22] Levy, D., Migraine pain, meningeal inflammation, and mast cells. Curr. Pain Headache Rep. 13:3 (2009 Jun), 237–240.
23. [23] Moskowitz, M.A., Cutrer, F.M., Sumatriptan: a receptor-targeted for migraine. Annu. Rev. Med. 44 (1993), 145–154.
24. [24] Waeber, C., Moskowitz, M.A., Migraine as an inflammatory disorder. Neurology 64 (2005), 9–15.
25. [25] Turan, Hale, Horasanli, Bahriye, Ugur, Murat, Arslan, Hande, Procalcitonin levels in migraine patients. Can. J. Neurol. Sci. 38 (2011), 124–128.
26. [26] de Jager, C.P., van Wijk, P.T., Mathoera, R.B., et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit. Care, 14(5), 2010, R192.
27. [27] Ear, T., McDonald, P.P., Cytokine generation, promoter activation, and oxidant-independent NF-kappaB activation in a transfectable human neutrophilic cellular model. BMC Immunol., 9, 2008, 14.
28. [28] Robertson, C.M., Coopersmith, C.M., The systemic inflammatory response syndrome. Microbes Infect. 8:5 (2006), 1382–1389.
29. [29] Tanrikulu, Yusuf, Sen Tanrikulu, Ceren, Zafer Sabuncuoglu, Mehmet, et al. Is the neutrophil-to-lymphocyte ratio a potential diagnostic marker for peptic ulcer perforation? A retrospective cohort study. Am. J. Emerg. Med. 34:3 (March 2016), 403–406, 10.1016/j.ajem.2015.11.009 pii: S0735–6757(15)00960-2.
30. [30] Buzzi, M.G., Moskowitz, M.A., The antimigraine drug, sumatriptan (GR43175) selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br. J. Pharmacol. 99 (1990), 202–206.